
Efficacy of Lebrikizumab in Adults and Adolescents with Moderate-To-Severe Atopic Dermatitis by Age of Onset: Analysis of Two Phase 3 Clinical Trials
This study was presented at the 33rd EADV Congress at Amsterdam by Drs Matthew Zirwas, Mark Boguniewicz et al from Dermatologists of the Central States,








